The fractionation dependence of tumor control in proton therapy for early-stage non-small cell lung cancer
Jeho Jeong, Vicki Trier Taasti, Andrew Jackson, Zeno A.R. Gouw, Charles B. Simone, Philippe Lambin, Joseph O. Deasy
This study evaluates how proton therapy's tumor control effectiveness varies with fractionation schedules in early-stage NSCLC, finding higher RBE for short-term treatments.
bioRxiv · Jan 23, 2025 · PreprintBiophysics